varenicline has been researched along with Depressive Disorder, Major in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anthenelli, RM; Beneventi, D; Blalock, JA; Cinciripini, PM; Green, C; Karam-Hage, M; Kypriotakis, G; Lawrence, D; Minnix, J; Morris, C | 1 |
| Bastian, J; Bauer, AM; Fox, EN; Gollan, JK; Hitsman, B; Hole, A; Huffman, MD; Khan, SS; Leone, FT; Lubitz, SF; Mohr, DC; Niaura, R; Papandonatos, GD; Schnoll, RA; Veluz-Wilkins, AK; Wileyto, EP | 1 |
| Colby, SM; Leggio, L; Martin, RA; Monti, PM; Rohsenow, DJ; Swift, RM; Tidey, JW | 1 |
| Bruguera, E; Cedillo, S; Rejas-Gutiérrez, J | 1 |
| Anthenelli, RM; Doran, N; Dubrava, S | 1 |
| Anthenelli, RM; Dubrava, SJ; Morris, C; Ramey, TS; Russ, C; Tsilkos, K; Yunis, C | 1 |
| Popkin, MK | 1 |
| Nadeem, SS; Pirmoradi, P; Roshan, S | 1 |
| Lyon, GJ | 1 |
5 trial(s) available for varenicline and Depressive Disorder, Major
| Article | Year |
|---|---|
The effects of varenicline, bupropion, nicotine patch, and placebo on smoking cessation among smokers with major depression: A randomized clinical trial.
Topics: Bupropion; Depression; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Polyesters; Smokers; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2022 |
Efficacy and safety of combination behavioral activation for smoking cessation and varenicline for treating tobacco dependence among individuals with current or past major depressive disorder: A 2 × 2 factorial, randomized, placebo-controlled trial.
Topics: Adult; Benzazepines; Depressive Disorder, Major; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2023 |
Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.
Topics: Adult; Cigarette Smoking; Comorbidity; Counseling; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Nicotinic Agonists; Patient Compliance; Rhode Island; Sex Factors; Smokers; Smoking Cessation; Substance-Related Disorders; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2017 |
Effects of Varenicline, Depressive Symptoms, and Region of Enrollment on Smoking Cessation in Depressed Smokers.
Topics: Adult; Aged; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotinic Agonists; Smokers; Smoking Cessation; Treatment Outcome; Varenicline | 2019 |
Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Benzazepines; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Suicidal Ideation; Treatment Outcome; Varenicline; Young Adult | 2013 |
5 other study(ies) available for varenicline and Depressive Disorder, Major
| Article | Year |
|---|---|
Modelling a budgetary impact analysis for funding drug-based smoking cessation therapies for patients with major depressive disorder in Spain.
Topics: Bupropion; Cost-Benefit Analysis; Depressive Disorder, Major; Female; Health Care Costs; Humans; Male; Markov Chains; Smoking; Smoking Cessation; Spain; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2017 |
Summaries for patients. Does varenicline help people with depression quit smoking?
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Benzazepines; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Suicidal Ideation; Treatment Outcome; Varenicline; Young Adult | 2013 |
Exacerbation of recurrent depression as a result of treatment with varenicline.
Topics: Aged; Benzazepines; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Recurrence; Smoking Cessation; Varenicline | 2008 |
Neuropsychiatric disturbance after initiation of varenicline in a patient with a history of alcohol abuse and major depression.
Topics: Adult; Alcoholism; Benzazepines; Depressive Disorder, Major; Humans; Male; Mental Disorders; Nervous System Diseases; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2008 |
Possible varenicline-induced paranoia and irritability in a patient with major depressive disorder, borderline personality disorder, and methamphetamine abuse in remission.
Topics: Adult; Amphetamine-Related Disorders; Benzazepines; Borderline Personality Disorder; Depressive Disorder, Major; Drug Partial Agonism; Female; Humans; Irritable Mood; Methamphetamine; Nicotinic Agonists; Paranoid Disorders; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline | 2008 |